
November 19, 2017 - By Louis Casey
First City Capital Management Inc increased Sanofi Aventis (SNY) stake by 42.08% reported in 2017Q2 SEC filing. First City Capital Management Inc acquired 11,370 shares as Sanofi Aventis (SNY)’s stock rose 14.25%. The First City Capital Management Inc holds 38,389 shares with $1.84 million value, up from 27,019 last quarter. Sanofi Aventis now has $112.36 billion valuation. The stock decreased 0.25% or $0.11 on November 17, reaching $44.54. About 661,417 shares traded. Sanofi SA (ADR) (NYSE:SNY) has risen 26.96% since November 19, 2016 and is uptrending. It has outperformed by 10.26% the S&P500. Lumentum Holdings Incorporated (NASDAQ:LITE) had an increase of 5.76% in short interest. LITE’s SI was 11.66M shares in November as released by FINRA. Its up 5.76% from 11.03M shares previously. With 1.93 million avg volume, 6 days are for Lumentum Holdings Incorporated (NASDAQ:LITE)’s short sellers to cover LITE’s short positions. The SI to Lumentum Holdings Incorporated’s float is 19.93%. The stock decreased 0.26% or $0.15 on November 17, reaching $57.5. About 1.42 million shares traded. Lumentum Holdings Inc (NASDAQ:LITE) has risen 145.74% since November 19, 2016 and is uptrending. It has outperformed by 129.04% the S&P500.Among 11 analysts covering Sanofi-aventis Sa (NYSE:SNY), 2 have Buy rating, 0 Sell and 9 Hold. Therefore 18% are positive. Sanofi-aventis Sa had 20 analyst reports since October 15, 2015 according to SRatingsIntel. On Thursday, October 15 the stock rating was upgraded by Morgan Stanley to “Overweight”. On Friday, April 7 the stock rating was downgraded by HSBC to “Reduce”. The stock has “Buy” rating by Berenberg on Thursday, September 8. The stock has “Mkt Perform” rating by Bernstein on Monday, November 9. The stock of Sanofi SA (ADR) (NYSE:SNY) has “Hold” rating given on Friday, October 13 by Cowen & Co. On Wednesday, November 15 the stock rating was upgraded by Barclays Capital to “Equal-Weight”. The rating was upgraded by HSBC to “Hold” on Wednesday, August 30. The firm has “Neutral” rating by JP Morgan given on Friday, April 21. Cowen & Co maintained Sanofi SA (ADR) (NYSE:SNY) rating on Tuesday, September 5. Cowen & Co has “Hold” rating and $52.0 target. Berenberg downgraded Sanofi SA (ADR) (NYSE:SNY) on Thursday, May 11 to “Hold” rating.Among 14 analysts covering Lumentum (NASDAQ:LITE), 6 have Buy rating, 3 Sell and 5 Hold. Therefore 43% are positive. Lumentum had 33 analyst reports since August 4, 2015 according to SRatingsIntel. The firm has “Equal Weight” rating given on Wednesday, August 5 by Barclays Capital. The stock has “Buy” rating by Stifel Nicolaus on Friday, February 5. The firm earned “Sell” rating on Tuesday, October 11 by Goldman Sachs. Goldman Sachs initiated it with “Neutral” rating and $21 target in Wednesday, August 5 report. The company was initiated on Thursday, September 24 by M Partners. The stock of Lumentum Holdings Inc (NASDAQ:LITE) earned “Buy” rating by Stifel Nicolaus on Wednesday, August 12. The company was downgraded on Friday, January 8 by Barclays Capital. The company was downgraded on Wednesday, September 9 by RBC Capital Markets. The stock of Lumentum Holdings Inc (NASDAQ:LITE) has “Outperform” rating given on Tuesday, August 18 by Northland Capital. The firm has “Buy” rating given on Wednesday, July 20 by M Partners.Lumentum Holdings Inc. is a provider of optical and photonic products for a range of end market applications, including data communications and telecommunications (Telecom) networking and commercial lasers (commercial lasers) for manufacturing, inspection and life-science applications. The company has market cap of $3.56 billion. The Firm operates in two divisions: Optical Communications (OpComms) and Commercial Lasers (Lasers). It currently has negative earnings. The Company’s OpComms products include a range of components, modules and subsystems to support and maintain clients in its two primary markets: Telecom and Datacom.Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.By1 Louis Casey



(adsbygoogle = window.adsbygoogle || []).push({});
